Chronic and Acute Leukemias: ClinicalThought™ 2015

Expert commentary and conversation: optimal treatment approaches for chronic and acute leukemias.

Share

Program Content

Activities

New Therapies for R/R ALL
New Options for Patients With Relapsed/Refractory ALL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 20, 2015

Expires: February 19, 2016

CLL Therapy: Fit Patients
How I Treat My Patients With CLL Who Are Fit or Otherwise Healthy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2015

Expires: March 09, 2016

AML Targeted Therapy
Acute Myeloid Leukemia: Will Understanding the Biology Lead to Better Outcomes?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 26, 2015

Expires: March 24, 2016

CML With Elevated BCR-ABL
A CML Patient With Elevated BCR-ABL at 3 Months: To Switch or Not to Switch?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 27, 2015

Expires: April 25, 2016

CLL Treatment Revolution
The CLL Treatment Revolution
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 26, 2015

Expires: May 24, 2016

Improving APL Outcomes
How Can We Further Improve Outcomes in Acute Promyelocytic Leukemia?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 18, 2015

Expires: June 16, 2016

Faculty

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

cover img faculity

Elias Jabbour, MD

Assistant Professor
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Novartis Oncology